X0206 3 2016-05-25 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001034320 WORTLEY MICHAEL D 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063 0 1 0 0 See Remarks Employee Stock Option (right to buy) 17.43 2025-03-31 Class B common stock 39184 D The option becomes exercisable as to 14,204 shares on April 1, 2016, and the remainder vests in twelve equal quarterly installments thereafter. The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date. Vice President, Chief Legal Officer /s/ Michael D. Wortley 2016-05-25